Department for Dermatology and Allergy, Allergy-Center-Charité, Charité Campus Mitte, Medical University Berlin, Germany.
Allergy. 2010 Jun 1;65(6):671-80. doi: 10.1111/j.1398-9995.2010.02332.x. Epub 2010 Feb 10.
The incidence of severe allergic reactions is largely unknown and information about triggering allergens, aggravating factors, demography of patients and medical care is lacking. A European wide registry could provide a powerful tool to improve the management of severe allergic reactions from both a medical and a public health perspective. Analysis of existing registries regarding the type and quality of data being collected was used to develop a plan for a pan-European registry, including the type of system to be used and the range of data to be entered. Surveillance will provide evidence for the efficacy of risk management measures and may identify the emergence of new allergenic foods, and aid monitoring of novel foods, ingredients and technologies. Patients need a clear indication of factors that may increase their risk of having an adverse reaction, which such a registry can help compile. Based on the collected data, food businesses will be able to develop educational programmes for allergen risk assessment and allergen risk communication. Finally, and most importantly preventive measures can be developed and government agencies receive population based data which may be relevant for legislative purposes.
严重过敏反应的发病率尚不清楚,有关致敏原、加重因素、患者人群和医疗保健的信息也缺乏。一个全欧范围的登记处可以提供一个有力的工具,从医疗和公共卫生的角度来改善严重过敏反应的管理。对现有的登记处进行分析,以了解所收集数据的类型和质量,从而制定泛欧登记处的计划,包括要使用的系统类型和要输入的数据范围。监测将为风险管理措施的有效性提供证据,并可能发现新的致敏性食物的出现,并有助于监测新型食物、成分和技术。患者需要明确了解可能增加不良反应风险的因素,而这样的登记处可以帮助汇总这些信息。基于收集到的数据,食品企业将能够制定过敏原风险评估和过敏原风险交流的教育计划。最后,也是最重要的是,可以制定预防措施,政府机构可以获得可能与立法目的相关的基于人群的数据。